May 24, 2000Goldline Brand Doxycycline
Hyclate Capsules and Indomethacin Capsules Recalled
FL (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Zenith Goldline Pharmaceuticals is
conducting a recall of Goldline Brand Doxycycline Hyclate Capsules and Indomethacin
Capsules because of mislabeling - Indomethacin Capsules were incorrectly labeled as
Doxycycline Hyclate Capsules.
The recalled Goldline Brand
Doxycycline Hyclate Capsules are 100 mg, in blister packs in boxes of 100 bearing the Lot
Number T-1474 EXP 10/01. The Indomethacin Capsules are 50 mg, in blister packs in
boxes of 100 and bear the T-1475 EXP 10/01.
FDA stated in its report that 970
boxes were distributed nationwide. The firm estimated that 50 percent of the product
remained on market at time of recall
This ongoing Class II recall
was initiated by the company, by letter beginning on April 10, 2000. This is the
first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-367/368-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 24, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.